Antitumor activity and safety of camrelizumab plus famitinib in patients with platinum-resistant recurrent ovarian cancer: results from an open-label, multicenter phase 2 basket studyLingfang Xia, Xiaohua Wu, Qi Zhou et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 39
Pain problems for patients with mild and moderate chronic obstructive pulmonary disease – a community-based study in ShanghaiTian Xiao, Chaowei Fu, Xianfeng Zhou et al.|Journal of Pain Research|2017Cited by 9